If you’ve followed the Cure JM research community over the years, you’ve likely heard Dr. Lisa Rider's name. Dr. Rider is known as one of the pioneers in JM research, and her work has seen several milestones in myositis progress.
Recently, Dr. Rider was inducted into the American Association of Physicians (AAP) for her vast contributions to pediatric rheumatology and myositis. AAP membership is limited to physicians who are also scientists who have made impactful research contributions to advance biomedical science, medicine, or health.
Dr. Rider and her team have led collaborations to identify genetic and environmental risk factors for myositis in children, classify patients’ symptoms, and uncover markers of disease progression and treatment response. Additionally, her work to quantify patient response to therapies has led to the development of the first FDA product to treat myositis in decades.
|